Stockscreener 앱 받기
62.91
2.20%
-1.32
Boston Scientific Corp 주식(BSX)의 최신 뉴스
Boston Scientific Shares Gain Following Positive Heart Implant Study - HarianBasis.co
Here’s What Piper Sandler Thinks About Boston Scientific Corp (BSX) Now - Yahoo Finance
Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
BSX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class ActionBSX - TMX Newsfile
ROSEN, THE FIRST FILING FIRM, Encourages Lufax Holding Ltd Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Boston Scientific Advances Fainting Detection Study With New Wearable Data Initiative - TipRanks
How FDA-Cleared Asurys and Galway R&D Expansion At Boston Scientific (BSX) Has Changed Its Investment Story - Yahoo Finance
Boston Scientific Corporation $BSX Position Lifted by Ninety One UK Ltd - MarketBeat
Boston Scientific Corp (NYSE:BSX) Presents a Compelling Growth and Technical Setup Case - ChartMill
Asset Management One Co. Ltd. Increases Stock Position in Boston Scientific Corporation $BSX - MarketBeat
AE Wealth Management LLC Boosts Stake in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp at TD Cowen Healthcare Conference Transcript - GuruFocus
Boston Scientific Corp Investor Event at the Scientific Session of the American College of Cardiology Transcript - GuruFocus
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class ActionBSX - TMX Newsfile
Boston Scientific Corp. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Boston Scientific Corporation (BSX) Price Target Lowered at Mizuho Ahead of Q1 Medical Device Earnings - Insider Monkey
Boston Scientific (BSX) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates - Yahoo Finance
BSX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - Barchart.com
Boston Scientific: The Company That Never Turned Around - Yahoo
INVESTOR DEADLINE: Boston Scientific Corporation (BSX) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - The Malaysian Reserve
Analysts Bullish on Boston Scientific (BSX) Amid Expectations for 30% YoY Growth in 2026 - Insider Monkey
BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Allegedly Misrepresenting Electrophysiology Procedure Growth - marketscreener.com
Boston Scientific plans $88.5M R&D expansion in Ireland - Yahoo Finance
Boston Scientific Corporation $BSX Position Increased by KBC Group NV - MarketBeat
Boston Scientific (BSX) Outperforms Broader Market: What You Need to Know - Yahoo Finance
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit - ChartMill
Boston Scientific Corp (BSX-N) Stock Price and News - The Globe and Mail
Truist cuts Boston Scientific stock price target on Watchman concerns By Investing.com - Investing.com South Africa
Truist cuts Boston Scientific stock price target on Watchman concerns - Investing.com
BSX Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
Truist Financial Cuts Boston Scientific (NYSE:BSX) Price Target to $90.00 - MarketBeat
Boston Scientific (BSX) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Baird Adjusts Boston Scientific Price Target to $86 From $95, Maintains Outperform Rating - marketscreener.com
Truist Trims Price Target on Boston Scientific to $90 From $92, Keeps Buy Rating - marketscreener.com
Boston Scientific invests €75m in Galway site - Business Post
Boston Scientific Corporation (BSX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Barchart.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines – BSX - ChartMill
Boston Scientific Corp. stock rises Tuesday, still underperforms market - MarketWatch
Cardiac Monitoring Devices Market Set for Sustained Growth at 5.17% CAGR Through 2034: DelveInsight | Philips, Medtronic, and Boston Scientific - Barchart.com
Citi Reiterates Buy rating for Boston Scientific (BSX) - Yahoo Finance
Boston Scientific Corp. stock (US10117L1017): Is medtech innovation strong enough to unlock new upsi - AD HOC NEWS
BOSTON SCIENTIFIC CORPORATION (BSX) DEADLINE ALERT Bernstein Liebhard LLP Reminds Boston Scientific Corporation Investors of Upcoming Deadline - TMX Newsfile
Fund Update: 486,715 BOSTON SCIENTIFIC (BSX) shares added to Bank Pictet & Cie (Europe) AG portfolio - Quiver Quantitative
BSX Shareholder Alert: Boston Scientific Corporation Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm - Barchart.com
RBC Cuts Price Target on Boston Scientific to $105 From $115, Keeps Outperform Rating - marketscreener.com
Faruqi & Faruqi, LLP Highlights Class Action Against Boston Scientific (BSX) and Upcoming Lead Plaintiff Deadline of May 4, 2026 - marketscreener.com
Will Boston Scientific (BSX) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Portnoy Law Firm Announces Class Action on Behalf of Boston Scientific Corporation Investors - GlobeNewswire
Sumitomo Mitsui Trust Group Inc. Trims Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat
Boston Scientific Corporation $BSX Shares Sold by Massachusetts Financial Services Co. MA - MarketBeat
Boston Scientific Corp. stock (US10117L1017): Is its medtech innovation edge strong enough to drive - AD HOC NEWS
Sowell Financial Services LLC Sells 21,713 Shares of Boston Scientific Corporation $BSX - MarketBeat
Why Boston Scientific's big dip could be a bigger opportunity - MSN
BSX Price History for Boston Scientific Corp Stock - Barchart
Boston Scientific (BSX) Receives FDA Clearance for Asurys Fluid Management System - Insider Monkey
Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch
ROSEN, A RANKED AND LEADING FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
BOSTON SCIENTIFIC CORPORATION (BSX) DEADLINE ALERT - GlobeNewswire
Boston Scientific Corp. stock rises Wednesday, still underperforms market - MarketWatch
Boston Scientific Faces Class Action Lawsuit from Shareholders - Intellectia AI
BSX INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Deals tracker: Orlando Health to acquire Alabama health system - Modern Healthcare
0.51%
0.15%
자본화:
|
볼륨(24시간):